EUVIMEDEUVIMED entdecken
Multizentrische Studie

Real-World Safety Analysis of Preschool Tree Nut Oral Immunotherapy

Stephanie C Erdle, Victoria E Cook, Scott B Cameron, Joanne Yeung, Sandeep Kapur, Mary McHenry, Edmond S Chan, Raymond Mak, Gregory A Rex, Tiffany Wong, Lianne Soller

The Journal of Allergy and Clinical Immunology: In Practice · 2023

DOI: 10.1016/j.jaip.2023.01.031 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Stephanie C Erdle und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Ca…. Hauptthemen laut MEDLINE: Nut Hypersensitivity, Peanut Hypersensitivity. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: BC Children’s Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Our group previously described preschool peanut oral immunotherapy (OIT) in a real-world, multicenter setting, suggesting that this therapy is safe for most preschoolers. OBJECTIVE: To examine the safety and tolerability of tree nut (TN) OIT in preschoolers in the real world. METHODS: As part of a Canada-wide quality improvement project, TN-OIT (cashew/pistachio, walnut/pecan, hazelnut, almond, and macadamia nut) was performed in preschoolers who had (1) a skin prick test wheal diameter greater than or equal to 3 mm or a specific IgE level greater than or equal to 0.35 kU/L and a convincing objective IgE-mediated reaction or (2) no ingestion history and a specific IgE level greater than or equal to 5 kU/L. Dose escalations were performed every 2 to 4 weeks till a maintenance dose of 300 mg of TN protein was reached. Symptoms were recorded and classified using the modified World Allergy Organization Subcutaneous Immunotherapy Reaction Grading System (1, mildest; 5, fatal). RESULTS: Of the 92 patients who started TN-OIT from 2018 to 2021, 79 (85.9%) underwent single-food TN-OIT and 13 (14.1%) underwent multifood TN-OIT to 2 (10.8%) or 3 (3.3%) TNs. Eighty-nine (96.7%) patients reached maintenance, and 4 (4.3%) dropped out. Sixty-five (70.7%) patients experienced reactions during buildup: 35 (38.0%) grade 1 reactions, 30 (32.6%) grade 2 reactions, no grade 3 or 4 reactions, and 2 (2.17%) received epinephrine. CONCLUSIONS: Preschool TN-OIT in a real-world, multicenter setting appears safe and tolerable, with results comparable with our previously reported peanut OIT findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nut HypersensitivityPeanut HypersensitivityChild, PreschoolHumansNutsImmunoglobulin EImmunotherapyAllergensArachisAdministration, OralDesensitization, Immunologic

Stichwörter der Autor:innen

AllergyHypersensitivityOral immunotherapyPediatricsTree nuts

Substanzen

Immunoglobulin EAllergens

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada. Electronic address: stephanie.erdle@cw.bc.ca.
  • Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada; Community Allergy Clinic, Victoria, British Columbia, Canada.
  • Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada; Vancouver Kids Allergy, Vancouver, British Columbia, Canada.
  • Division of Allergy, Department of Pediatrics, Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada; Halifax Allergy and Asthma Associates, Halifax, Nova Scotia, Canada.
  • Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada.

Förderung

  • BC Children’s Hospital Foundation

Zitieren

APA

Erdle, S. C., Cook, V. E., Cameron, S. B., Yeung, J., Kapur, S., McHenry, M., Chan, E. S., Mak, R., Rex, G. A., Wong, T., & Soller, L. (2023). Real-World Safety Analysis of Preschool Tree Nut Oral Immunotherapy. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.01.031

Vancouver

Erdle SC, Cook VE, Cameron SB, Yeung J, Kapur S, McHenry M, et al. Real-World Safety Analysis of Preschool Tree Nut Oral Immunotherapy. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.01.031

BibTeX
@article{Erdle2023,
  author = {Erdle, Stephanie C and Cook, Victoria E and Cameron, Scott B and Yeung, Joanne and Kapur, Sandeep and McHenry, Mary and Chan, Edmond S and Mak, Raymond and Rex, Gregory A and Wong, Tiffany and Soller, Lianne},
  title = {Real-World Safety Analysis of Preschool Tree Nut Oral Immunotherapy},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2023},
  doi = {10.1016/j.jaip.2023.01.031}
}
Kostenlos starten →